The FDA has identified the type of recall as serious, with a risk of medication overdose and death when continuing to use the product, according to a Sept. 16 news release from the agency.
The affected product is the Ivenix LVP Primary Administration Sets Dual-Inlet, Low-Sorbing, Needle-Free Port, Y-Site. The manufacturer sent affected customers a letter recommending the destruction or return of the affected product and that replacements be requested.
There have been two reported injuries, the release said.
Editor’s note: This article was updated Sept. 18 at 2:45 p.m. CT.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
